This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Connect for Cancer Prevention Study (Connect) | MicrobiomeTrials
← Back to trials NCT04609072
Connect for Cancer Prevention Study (Connect) Recruiting OBSERVATIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2021-07-26Est. Completion: 2070-12-31
Enrollment target: 200,000 participantsLocations Kaiser Permanente Colorado, Denver, Colorado, United States Kaiser Permanente Georgia, Atlanta, Georgia, United States Kaiser Permanente Hawaii, Honolulu, Hawaii, United States University of Chicago Medical Center, Chicago, Illinois, United States Henry Ford Health Systems, Detroit, Michigan, United States HealthPartners, Minneapolis, Minnesota, United States Kaiser Permanente Northwest, Portland, Oregon, United States Sanford Health, Sioux Falls, South Dakota, United States Baylor Scott and White Health, Dallas, Texas, United States Marshfield Clinic Health System, Marshfield, Wisconsin, United States Other microbiome trials you might be interested in Ovarian Cancer Recurrent Ovarian Cancer Platinum Resistant Ovarian Cancer
The goal of this clinical trial is to learn if OPB-101 is safe in platinum resistant ovarian cancer participants and als…
Detroit, United States Completed Sep 30, 2026
Lung Neoplasms Neoadjuvant Therapy Immunotherapy Minimal Residual Disease
This study is a prospective single-arm clinical trial targeting patients with stage IB-IIIA non-small cell lung cancer (…
Beijing, China Est. completion Oct 31, 2027
Recurrent Breast Carcinoma Stage III Breast Cancer AJCC v7 Stage IIIA Breast Cancer AJCC v7 Stage IIIB Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7 Stage IV Breast Cancer AJCC v6 and v7
This randomized phase II trial studies how well tamoxifen citrate works compared with z-endoxifen hydrochloride in treat…
Mobile, United States Est. completion Nov 6, 2020